ArticleFrontiers in immunology2026

Long-term immunity and protection against SARS-CoV-2 XBB.1.5 following homologous and heterologous mRNA and MVA vaccination.

Patricia Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.